Teladoc Health executive Nueno Carlos exercised Options for 13,273 shares across two transactions on 2026-09-01, then sold 6,200 shares at $6.30 on 2026-09-02. The transactions left him with 64,744 shares and 52,302 derivative securities, giving investors the reported post-transaction ownership figures.
Key Highlights
- Nueno Carlos sold 6,200 Teladoc Health shares at $6.30 each on 2 September 2026.
- Carlos owned 64,744 Teladoc Health shares after the sale.
- His derivative-security holdings stood at 52,302 after the option exercises.
Teladoc Health, Inc. (NYSE: TDOC) executive Nueno Carlos exercised options for 13,273 shares across two transactions on 1 September 2026. Carlos, the company’s President, International, owned 70,944 shares after those transactions.
Teladoc Executive’s Option Exercises and Share Sale
The option exercises covered 13,273 derivative securities at $0 per share, with the transactions marked under SEC transaction code M. Carlos subsequently sold 6,200 shares at $6.30 per share on 2 September 2026, using SEC transaction code S. Following the sale, Carlos owned 64,744 shares. Derivative-security ownership stood at 52,302 following the option exercises. The filing reports transactions involving Teladoc Health, Inc. shares and derivative securities owned by Carlos.
FAQs
Q: How many Teladoc Health options did Nueno Carlos exercise?
A: Nueno Carlos exercised options for 13,273 Teladoc Health shares across two transactions on 1 September 2026. The related derivative securities carried an exercise price of $0 per share.
Q: How many Teladoc Health shares did Nueno Carlos sell?
A: Carlos sold 6,200 Teladoc Health shares on 2 September 2026 at $6.30 per share. His reported share ownership afterward was 64,744 shares.
Q: What were Nueno Carlos’s post-transaction Teladoc holdings?
A: Carlos owned 64,744 Teladoc Health shares after the sale. His derivative-security holdings totaled 52,302 following the option exercises, as reported in the filing.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.